We are live on
!
Find out more
SFI
Susquehanna Fundamental Investments Portfolio holdings
AUM
$2.67B
1-Year Est. Return
21.74%
This Fund
S&P 500
This Quarter
Est. Return
+4.52%
1 Year Est. Return
+21.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7B
AUM Growth
–
Cap. Flow
+$7.03B
Cap. Flow
% of AUM
100.51%
Top 10 Holdings %
Top 10 Hldgs %
21.09%
Holding
1,064
New
1,064
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$70.7M |
| 2 |
Philip Morris
PM
|
+$50.7M |
| 3 |
PayPal
PYPL
|
+$46.8M |
| 4 |
Tesla
TSLA
|
+$45.1M |
| 5 |
Starbucks
SBUX
|
+$44.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.6% |
| 2 | Industrials | 12.48% |
| 3 | Healthcare | 12.29% |
| 4 | Technology | 12.25% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODV
1026
DELISTED
ModivCare
MODV
| $144K | ﹤0.01% |
+12,145
| New | +$192K |
|
|
ESPR
1027
DELISTED
Esperion Therapeutics
ESPR
| $144K | ﹤0.01% |
+65,260
| New | +$152K |
|
|
PSTX
1028
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $134K | ﹤0.01% |
+13,927
| New | +$72.7K |
|
|
MRSN
1029
DELISTED
Mersana Therapeutics
MRSN
| $131K | ﹤0.01% |
+3,674
| New | +$190K |
|
1030
Amplify Energy
AMPY
$182M
| $131K | ﹤0.01% |
+21,845
| New | +$143K |
|
1031
Leggett & Platt
LEG
$1.29B
| $131K | ﹤0.01% |
+13,600
| New | +$163K |
|
1032
IHS Holding
IHS
$2.82B
| $128K | ﹤0.01% |
+43,902
| New | +$133K |
|
1033
N-able
NABL
$612M
| $123K | ﹤0.01% |
+13,165
| New | +$148K |
|
1034
Barnes & Noble Education
BNED
$417M
| $122K | ﹤0.01% |
+12,177
| New | +$125K |
|
1035
Inovio Pharmaceuticals
INO
$79.6M
| $120K | ﹤0.01% |
+65,669
| New | +$291K |
|
1036
CleanSpark
CLSK
$3.13B
| $115K | ﹤0.01% |
+12,500
| New | +$151K |
|
1037
Savers
SVV
$1.65B
| $114K | ﹤0.01% |
+11,100
| New | +$110K |
|
1038
Granite Ridge Resources
GRNT
$674M
| $109K | ﹤0.01% |
+16,947
| New | +$105K |
|
1039
Enanta Pharmaceuticals
ENTA
$393M
| $105K | ﹤0.01% |
+18,346
| New | +$176K |
|
|
RERE
1040
ATRenew
RERE
$988M
| $101K | ﹤0.01% |
+35,195
| New | +$97.9K |
|
1041
Aurinia Pharmaceuticals
AUPH
$2.06B
| $89.8K | ﹤0.01% |
+10,001
| New | +$81.6K |
|
1042
Ribbon Communications
RBBN
$372M
| $88.8K | ﹤0.01% |
+21,338
| New | +$80.6K |
|
1043
ProKidney
PROK
$304M
| $88.1K | ﹤0.01% |
+52,128
| New | +$94K |
|
1044
Designer Brands
DBI
$311M
| $83.8K | ﹤0.01% |
+15,690
| New | +$87.8K |
|
|
DCH
1045
Dauch Corp
DCH
$1.61B
| $81.3K | ﹤0.01% |
+13,939
| New | +$87.2K |
|
|
TSE
1046
DELISTED
Trinseo
TSE
| $80.3K | ﹤0.01% |
+15,742
| New | +$77.7K |
|
1047
NGL Energy Partners
NGL
$2.12B
| $79.1K | ﹤0.01% |
+15,854
| New | +$70.9K |
|
1048
Ranpak Holdings
PACK
$464M
| $71.3K | ﹤0.01% |
+10,357
| New | +$70.9K |
|
1049
Seanergy Maritime Holdings
SHIP
$348M
| $70.1K | ﹤0.01% |
+10,086
| New | +$90.6K |
|
1050
iHeartMedia
IHRT
$450M
| $69.9K | ﹤0.01% |
+35,316
| New | +$74.8K |
|
Similar funds
TCAM
VA
MMEA
PCIG
MG
CCM
ACM
LP
Susquehanna Fundamental Investments's Q4 2024 Portfolio in Review
As of Q4 2024, Susquehanna Fundamental Investments held 1,064 positions worth $7B. Its ten largest holdings account for 21% of the portfolio.
Susquehanna Fundamental Investments deployed $7.03B of net new capital in Q4 2024, opening 1,064 new positions. Its largest new stake was JPMorgan Chase: 303,656 shares worth $72.8M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, followed by Industrials and Healthcare.
- Susquehanna Fundamental Investments's largest Q4 2024 buy was JPMorgan Chase: 303,656 shares worth $72.8M.
- Susquehanna Fundamental Investments's ten largest holdings make up 21% of its $7B portfolio in Q4 2024.
- Susquehanna Fundamental Investments opened 1,064 new positions and closed 0 in Q4 2024.
Based on Susquehanna Fundamental Investments's 13F filing for Q4 2024, filed 14 Feb 2025.